Terms: = Leukemia AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
25 results:
1. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. [Immune Reconstitution after BTKi treatment in Chronic Lymphocytic leukemia].
Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
[TBL] [Abstract] [Full Text] [Related]
4. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract] [Full Text] [Related]
5. Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.
Visram A; De La Torre A; White D; Su J; Masih-Khan E; Chu M; Jimenez-Zepeda V; McCurdy A; LeBlanc R; Song K; Mian H; Louzada M; Sebag M; Bergstrom D; Stakiw J; Reiman A; Kotb R; Aslam M; Venner C; Kaedbey R; Gul E; Reece D
Blood Cancer J; 2023 Dec; 13(1):181. PubMed ID: 38065967
[TBL] [Abstract] [Full Text] [Related]
6. [Interim results of a multicenter cohort study for Chinese Children leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
7. NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.
Hwang WL; Chen TC; Lin HY; Chang MC; Hsiao PC; Bai LY; Kuo CY; Chen YC; Liu TC; Gau JP; Wang PN; Hwang WS; Kuo MC; Liu CY; Liu YC; Ma MC; Su NW; Wang CC; Wu YY; Yao M; Yeh SP; Cheng HW; Lee YM; Ku FC; Tang JL
Int J Hematol; 2022 May; 115(5):704-712. PubMed ID: 35212915
[TBL] [Abstract] [Full Text] [Related]
8. Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid leukemia in Need of Chemotherapy Augmentation.
Elsayed AH; Cao X; Mitra AK; Wu H; Raimondi S; Cogle C; Al-Mansour Z; Ribeiro RC; Gamis A; Kolb EA; Aplenc R; Alonzo TA; Meshinchi S; Rubnitz J; Pounds S; Lamba JK
J Clin Oncol; 2022 Mar; 40(7):772-783. PubMed ID: 34990262
[TBL] [Abstract] [Full Text] [Related]
9. New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.
Dalla Via V; Halter JP; Gerull S; Arranto C; Tichelli A; Heim D; Passweg JR; Medinger M; Cesana-Nigro N
In Vivo; 2020; 34(6):3545-3549. PubMed ID: 33144466
[TBL] [Abstract] [Full Text] [Related]
10. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.
Ueno H; Yoshida K; Shiozawa Y; Nannya Y; Iijima-Yamashita Y; Kiyokawa N; Shiraishi Y; Chiba K; Tanaka H; Isobe T; Seki M; Kimura S; Makishima H; Nakagawa MM; Kakiuchi N; Kataoka K; Yoshizato T; Nishijima D; Deguchi T; Ohki K; Sato A; Takahashi H; Hashii Y; Tokimasa S; Hara J; Kosaka Y; Kato K; Inukai T; Takita J; Imamura T; Miyano S; Manabe A; Horibe K; Ogawa S; Sanada M
Blood Adv; 2020 Oct; 4(20):5165-5173. PubMed ID: 33095873
[TBL] [Abstract] [Full Text] [Related]
11. Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis.
Tremblay D; King A; Li L; Moshier E; Coltoff A; Koshy A; Kremyanskaya M; Hoffman R; Mauro MJ; Rampal RK; Mascarenhas J
Leuk Lymphoma; 2020 Mar; 61(3):660-667. PubMed ID: 31711337
[TBL] [Abstract] [Full Text] [Related]
12. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
Morton LM; Sampson JN; Armstrong GT; Chen TH; Hudson MM; Karlins E; Dagnall CL; Li SA; Wilson CL; Srivastava DK; Liu W; Kang G; Oeffinger KC; Henderson TO; Moskowitz CS; Gibson TM; Merino DM; Wong JR; Hammond S; Neglia JP; Turcotte LM; Miller J; Bowen L; Wheeler WA; Leisenring WM; Whitton JA; Burdette L; Chung C; Hicks BD; Jones K; Machiela MJ; Vogt A; Wang Z; Yeager M; Neale G; Lear M; Strong LC; Yasui Y; Stovall M; Weathers RE; Smith SA; Howell R; Davies SM; Radloff GA; Onel K; Berrington de González A; Inskip PD; Rajaraman P; Fraumeni JF; Bhatia S; Chanock SJ; Tucker MA; Robison LL
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059430
[TBL] [Abstract] [Full Text] [Related]
13. Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to imatinib: a cost-effectiveness analysis based on real-world data.
Li N; Yang X; Fan L; Totev T; Guerin A; Chen L; Bhattacharyya S; Joseph G
J Med Econ; 2017 Apr; 20(4):328-336. PubMed ID: 27841717
[TBL] [Abstract] [Full Text] [Related]
14. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract] [Full Text] [Related]
15. Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Proetel U; Pletsch N; Lauseker M; Müller MC; Hanfstein B; Krause SW; Kalmanti L; Schreiber A; Heim D; Baerlocher GM; Hofmann WK; Lange E; Einsele H; Wernli M; Kremers S; Schlag R; Müller L; Hänel M; Link H; Hertenstein B; Pfirrman M; Hochhaus A; Hasford J; Hehlmann R; Saußele S; ;
Ann Hematol; 2014 Jul; 93(7):1167-76. PubMed ID: 24658964
[TBL] [Abstract] [Full Text] [Related]
16. [Expression of CYR61, CTGF, VEGF-C, VEGFR-2 mRNA in bone marrow of leukemia patients and its clinical significance].
Xu N; He QT; Lu Y; Han XM; Ma HJ; Zhang DX; Liu XW; Yuan XJ; Jia GR; Li J; Li Z; Li ZQ; Han HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1368-73. PubMed ID: 22169285
[TBL] [Abstract] [Full Text] [Related]
17. Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.
Imataki O; Kamioka T; Fukuda T; Tanosaki R; Takaue Y
Support Care Cancer; 2010 Dec; 18(12):1565-9. PubMed ID: 20967555
[TBL] [Abstract] [Full Text] [Related]
18. Trimming of mammalian transcriptional networks using network component analysis.
Tran LM; Hyduke DR; Liao JC
BMC Bioinformatics; 2010 Oct; 11():511. PubMed ID: 20942926
[TBL] [Abstract] [Full Text] [Related]
19. Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.
Behrendt CE; Rosenthal J; Bolotin E; Nakamura R; Zaia J; Forman SJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):54-60. PubMed ID: 19135943
[TBL] [Abstract] [Full Text] [Related]
20. Cyclosporin A inhibits HTLV-I tax expression and shows anti-tumor effects in combination with VP-16.
Ozaki A; Arima N; Matsushita K; Uozumi K; Akimoto M; Hamada H; Kawada H; Horai S; Tanaka Y; Tei C
J Med Virol; 2007 Dec; 79(12):1906-13. PubMed ID: 17935163
[TBL] [Abstract] [Full Text] [Related]
[Next]
